NVIDIA CLARA DISCOVERY

Accelerated Computational Drug Discovery

Built to support cross-disciplinary workflows, NVIDIA Clara™  Discovery combines the power of accelerated computing, AI, and machine learning to supercharge the entire drug development process, unlocking the potential to bring life-saving drugs to market faster.

GPU-Powered Drug Discovery

Clara Discovery is a collection of frameworks, applications, and AI models

Apply AI and HPC to Drug Research

Clara Discovery is a collection of frameworks, applications, and AI models enabling GPU-accelerated drug discovery, with support for research in genomics, proteomics, microscopy, virtual screening, computational chemistry, visualization, clinical imaging, and natural language processing (NLP). Browse these tools in the NGC™ catalog, NVIDIA’s hub for GPU-optimized software.

Power Data-Driven Pharma R&D

Clara Discovery is optimized to run on NVIDIA DGX™ A100, the world’s most advanced AI system delivering five petaFLOPS of performance. Purpose-built for all accelerated computing workloads at scale, DGX A100 provides researchers the fastest time to solution and IT a unified, easy-to-deploy infrastructure to support the next-generation of drug discovery.

 View HPC Application Performance

 View Deep Learning Framework Performance

Full Stack Acceleration

Clara Discovery Partners

Atomwise
Entos
insilico.com
Schrodinger
Structura Biotechnology Inc
Vyasa

Sign up for the latest healthcare news from NVIDIA